Abiopharma

🔍 Cummings George W. III (Director)

Company: Business First Bancshares, Inc. (BFST)

Report Date: 2026-08-21

Detailed Transactions and Holdings:

• Sold 4,200 shares of COMMON STOCK at $31.27 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 193,745.00 | transaction_form_type: 4
• Sold 10,000 shares of COMMON STOCK at $31.33 per share (Direct)
  Date: 2026-08-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 183,745.00 | transaction_form_type: 4
• Holds 0 shares of COMMON STOCK (Direct)
  Date: 2026-08-21 | Code: H | nature_of_ownership: By Spouse | shares_owned_after: 3,911.00
• Holds 998 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-21 | Code: H | shares_owned_after: 998.00 | Footnotes: F1, F1

Footnotes:

• F1: The time-based restricted stock units were granted to the reporting person on June 25, 2026, under the Business First Bancshares, Inc. 2024 Equity Incentive Plan. The time-based restricted stock units will fully vest on June 25, 2027. Each time-based restricted stock unit is economically equivalent to one share of common stock of the issuer. Under the terms of the relevant restricted stock unit grant, the reported unvested restricted stock units are subject to forfeiture upon the occurrence of certain events.